# Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer

> **NCT05052099** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Essen** · enrollment: 20 (actual)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **DRUG:** mFOLFOX6, Atezolizumab and Bevacizumab

## Key facts

- **NCT ID:** NCT05052099
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-22
- **Primary completion:** 2024-09-18
- **Final completion:** 2024-09-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05052099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05052099, "Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05052099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*